Additional information
Mikrogen recomLine CMV tests are serological, qualitative in vitro line immunoassays based on recombinantly produced antigens.
The test is used as a confirmatory test of positive and inconclusive screening results. The low predictive value of a positive
CMV IgM detection, due to persistent IgM or recurrent infection, makes reliable diagnosis of CMV infection particularly difficult.
Using the recomLine CMV, IgG, IgM as well as the avidity of IgG antibodies can be determined. Phase-specific antigens and avidity
antigens (patented by MIKROGEN on the Immuno-Line Assay) allow detection of antibodies in all phases of infection. In addition to
viral load, the recomLine CMV can be used in pregnancy diagnostics as well as in preoperative diagnostics in transplant patients
to detect CMV infection and to determine the time of infection.
The recomLine CMV tests provide a clear answer to the question of what effects the present infection may have on the health
status of the individual patient and thus support an optimal therapy decision.
Advantages
- Highly reliable patient management through the use of phase-specific antigens that characterize the time of infection.
- Reliable detection of pregnancy-related CMV infections.
- Simple and clear interpretation due to easy-to-read banding.
- Partial and full automation, software-based evaluation (recomScan), and integration with laboratory information system possible.
- Highest sensitivity and specificity through the use of recombinant antigens:
Bands
| Antigen |
Reading Frame/Protein |
Natural Function |
Size [kDA] |
| IE 1 |
UL 123 / IE 1/1 |
Non-structural protein, immediate early protein |
53 |
| CM2 |
UL44, UL57 / p52 (DBP) |
Non-structural protein |
45 |
| p150 |
UL32 / pp150 |
Tegument protein |
50 |
| p65 |
UL 83 / pp65 |
Tegument protein |
31 |
| gB 1 |
UL 55 / gB |
Membrane glycoprotein gB |
25 |
| gB 2 |
UL 55 / gB |
M | | target relevance |
|---|
Organism
Cytomegalovirus | Structure and strains
Cytomegalovirus (CMV) is a genus of viruses in the order Herpesvirales, in the family Herpesviridae, in the subfamily Betaherpesvirinae. Humans and other primates serve as natural hosts. The 11 species in this genus include human betaherpesvirus 5 (HCMV, human cytomegalovirus, HHV-5), which is the species that infects humans. Diseases associated with HHV-5 include mononucleosis and pneumonia, and congenital CMV in infants can lead to deafness and ambulatory problems.
In the medical literature, most mentions of CMV without further specification refer implicitly to human CMV. Human CMV is the most studied of all cytomegaloviruses. | Disease
Cytomegalovirus (CMV) is a human pathogenic DNA virus belonging to the herpes virus group. Primary infection may result from contact with saliva, genital secretions, urine and breast milk of infected persons, as well as from transfusions or transplantations.
Primary infections usually remain asymptomatic. Clinical manifestations vary considerably depending on age and immunocompetence ranging from localized infections to generalized diseases. Significant clinical diseases or death may follow infection of immunocompromized individuals. Reactivation in immunocompetent adults is usually asymptomatic but accompanied by virus secretion. In immunocompromized patients reactivation of CMV infections may result in clinically severe diseases. CMV infection is a major cause of complications in iatrogenic immunsuppression after organ transplantation and in HIV infected persons. CMV is the most important causative agent of congenital and postnatal infections. Primary infections as well as reactivations during pregnancy may result in fetopathy. The risk of fetal damage is higher in cases of primary infections than during reactivations. | Detection and diagnosis
The diagnosis of CMV infections is performed on the basis of clinical symptoms and medical examinations. For serological diagnosis immunoglobulin specific IgM and IgG ELISA and, when necessary, tests for avidity determination are recommended. |
Data
PublicationsPublications
| pmid |
title |
authors |
citation |
| We haven't added any publications to our database yet. |
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.
Documents
| # |
|
|
| Please enter your product and batch number
here
to retrieve product datasheet, SDS, and QC information. |
|
